Trastuzumab deruxtecan in patients with central nervous system involvement from HER2-positive breast cancer: The DEBBRAH trialJosé Manuel Pérez-García, Sofía Braga, Patricia Cortez et al.|Neuro-Oncology|2022Cited by 247